2021 annual financial data
Skye Bioscience 2021 Operating cash flow
Direct answer
Operating cash flow was -6,474,888 USD.
Operating income was -7,847,714 USD and net income was -8,522,182 USD.
Operating cash flow was -6,474,888 USD.
Get free Skye Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,847,714 USD
- Net income
- -8,522,182 USD
- Operating cash flow
- -6,474,888 USD